The Clorox Company (NYSE:CLX) Shares Sold by WCM Investment Management LLC

WCM Investment Management LLC lowered its position in shares of The Clorox Company (NYSE:CLX) by 54.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,387 shares of the company’s stock after selling 4,079 shares during the quarter. WCM Investment Management LLC’s holdings in Clorox were worth $547,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Brooklyn Investment Group grew its stake in shares of Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after purchasing an additional 95 shares during the last quarter. Prospera Private Wealth LLC bought a new stake in Clorox during the third quarter worth approximately $27,000. Continuum Advisory LLC grew its position in Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after buying an additional 138 shares during the last quarter. Carolina Wealth Advisors LLC bought a new position in shares of Clorox in the third quarter valued at $48,000. Finally, Friedenthal Financial acquired a new stake in shares of Clorox during the 3rd quarter valued at $49,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Stock Down 0.9 %

CLX opened at $147.08 on Tuesday. The company has a market capitalization of $18.21 billion, a PE ratio of 40.18, a price-to-earnings-growth ratio of 2.52 and a beta of 0.42. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.62. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The business has a 50-day moving average of $161.06 and a 200-day moving average of $159.07.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the previous year, the firm earned $2.16 earnings per share. Equities research analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.32%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is 133.33%.

Analyst Ratings Changes

CLX has been the topic of a number of recent analyst reports. DA Davidson cut their target price on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 5th. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and boosted their price objective for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. Barclays upped their price objective on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research note on Wednesday, February 5th. JPMorgan Chase & Co. lifted their target price on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 4th. Finally, Wells Fargo & Company upped their price target on shares of Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 4th. Four research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $158.21.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.